R275G (p.Arg275Gly) variant of GCK (Hexokinase-4)

R275G (p.Arg275Gly) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes population frequency data and structural context.

R275G (p.Arg275Gly) variant details